As of today, inoculations using Astrazeneca's vaccines are put on pause in Denmark as a consequence of an investigation at the European Medicines Agency (EMA) evaluating the potential side effects of the vaccine.
"For cautionary reasons, the [Danish] Ministry of Health has paused Astrazeneca vaccinations following signs of a possible serious side effect in the form of lethal blood clots. Currently, we cannot conclude whether the two things are connected. We're acting early on, and this must be investigated thoroughly," Danish Minister for Health Magnus Heunicke says on Twitter.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.